Summary
In public health, the prevalence of use of CAM interventions is a key issue. The utilisation of specific methods such as acupuncture, homeopathy, herbal medicine, massage, reflexology and Reiki healing has increased exponentially in Western industrialized nations over the last 25 years [4, [7] [8] [9] . The World Health Organisation (WHO) Centre for Health Development published a global atlas of traditional, complementary and alternative medicine comprising a text and a map volume [10] . The WHO concluded that CAM is highly prevalent in the European region but was unable to draw a clear picture of CAM use across the whole EU as the evidence available was drawn from just a few member states. There is an urgent need to gather more information to gain an overview of the issues surrounding CAM, its availability and its safe and legitimate provision to EU citizens. There are currently no reliable comparisons between EU member states because they use different definitions with respect to CAM and the associated treatment methods [11] . EU-wide consensus in this field is essential to develop an understanding of EU citizens' behaviour with respect to CAM and to establish appropriate health policies in this area.
Objectives
In accordance with the call for proposals published on September 3, 2008 by the EC for the FP7-Health-2009 work programme [12] , CAMbrella is designed to fulfil the following specific objectives: -To develop consensus on a series of definitions for the terminology used to describe the major CAM interventions used clinically in Europe. -To create a knowledge base that allows us to accurately evaluate the patient demands for CAM and the prevalence of its use in Europe. -To review the current legal status of CAM in EU member or associated states. -To explore the needs and attitudes of EU citizens with respect to CAM. -To explore the providers' perspectives on CAM treatment in Europe. -To propose an appropriate research strategy for CAM that will help develop an understanding of CAM use and its effectiveness within an EU context in response to the needs of healthcare funders, providers and patients. This will take account of the issues of effectiveness, cost, safety and the legal requirements for the production of medicinal substances. -To develop a process for prioritizing future EU research strategy, the current policies within the EU have to be considered. -To facilitate and foster sustainable, high quality collaboration and networking of European CAM researchers.
Introduction and Rationale
The status of complementary and alternative medicine (CAM) in Europe is characterized by enormous heterogeneity in all aspects. This includes the terminology used, the methods provided, the prevalence, as well as the national legal status and regulation [1, 2] . The diversity and plurality of opinions and attitudes towards CAM, even within a relatively small academic CAM community, renders a coordinated European approach to CAM research difficult. Consequently, a comprehensive coordination action presents a thoughtful strategic response to this challenge. Europe-based research in this field is limited because of the restricted funding available; for instance in the UK 0.0085% of medical research funds are spent on CAM research. By contrast, more than 10% of the UK population use CAM each year and approximately 50% are lifetime users [3] ; in Germany, as another example, 1-year prevalence of use is reported to be around 60% [4] . Previous CAM projects funded by European authorities include 'COST B4', a project on unconventional medicine in Europe set up by the European Commission (1993) (1994) (1995) (1996) (1997) (1998) . It rendered findings on socio-cultural aspects, research methodology and dialogue between unconventional and orthodox medicine, and made recommendations for future work in this field [5] . However, the complex and ambitious recommendations were not implemented in EU or national research strategy, restricting the long-term impact of COST B4 to providing a clear strategic concept. Unlike these projects, CAMbrella is the first EU framework programme coordination action that is explicitly related to CAM in general and not focused on a specific condition. Besides this, the view currently taken in European health policy is also pointed out in Decision No. 1350/2007/EC which stipulates that the Second Programme of Community Action in the Field of Health 'should recognise the importance of a holistic approach to public health' and that CAM should be taken into account in its actions 'where appropriate and where there is scientific or clinical evidence' [6] . EU member states ( fig. 1 ). Further criteria were previous experience in international cooperation and a neutral position with respect to individual treatment methods or the interests of manufacturers of natural health products. The project is assisted by an advisory board in order to obtain input from the diverse CAM stakeholder groups including consumers, practitioners, clinical providers, and manufacturers of CAM medicinal products (table 2) . Most of the institutions that have joined the board are umbrella organizations which operate at European level and thus represent a significant number of members. The board members provide advice on healthcare and technical and political issues, thereby complementing the scientific perspective of the consortium.
Work Plan
The project's work plan is divided into a total of 9 work packages (WPs), comprising content-related WPs (WP1-WP7), one for disseminating the project results (WP8) and one dedi-
Consortium
To achieve the project's goals, a consortium was established which encompasses 16 partners predominantly affiliated to universities from 12 European countries with nearly 40 scientists and experts in research and clinical practice directly involved (table 1) . CAMbrella is coordinated and monitored by a management board and directed by a scientific steering committee with support of an advisory board and involves all the major stakeholders in CAM research in Europe. In addition to the authors of this article, the consortium includes Francesco Cardini (Italy), Gérard Delahaye (France), Simona Dragan (Romania), Gabriella Hegyi (Hungary), Paolo Roberti di Sarsina (Italy) and Jorge Vas (Spain). The current composition of the consortium is the result of a dynamic process initiated by an ad-hoc working group in December 2006. Further participants have been included during the preparatory phase of the project. Inclusion criteria were the participants' qualification with respect to the overall objective of the project and a preferably broad geographical representation of The majority of the WPs will deliver their outputs in the form of written reports which will be published in peer-reviewed journals and will be accessible to the public. One of the major tasks of the CAMbrella coordination action is to establish a reliable European network extending beyond the project consortium. The main centres of excellence in the field have been invited to cooperate. Face-to-face meetings between the partners will facilitate the exchange of ideas and thus enhance sustainable relations among the consortium members. Communication as well as the administrative project management is supported by the software tool Projectplace™ providing access for all project members. We Table 3 . Brief description of the objectives of CAMbrella Work Packages 1-9, (L) indicates the Work Package leader position
WP1: Terminology and definitions of CAM methods

Work group members: UZH (L), US, ComCAM, KI, SMBH, SAS
-Identifying and analyzing the existing terms and definitions of CAM used in scientific publications.
-Providing a core set of CAM disciplines and methods being used consistently all over Europe and an additional list of country-specific CAM disciplines and methods. -Developing a proposal for a practical pan-European definition of CAM, its disciplines and respective methods.
WP2: Legal status and regulations
Work group members: NAFKAM (L), ComCAM, KI, SMBH, PTE
Report on the current status with respect to: -legal status of CAM -regulatory status and governmental supervision of CAM practices -reimbursement status of CAM practices and medicinal products -regulation of CAM medicinal products -status of EU-wide regulation of CAM practices and medicinal products -potential obstacles for EU-wide regulation of CAM practices and medicinal products. 
WP3: Needs and attitudes of citizens
Work group members: SDU (L), GAMED, MRI, SMBH
Work group members: Charite (L), MRI, NAFKAM, UNIBE, US, UZH, ASSR, SDU
-Analysis of the research methods already used to identify prevalence and use of CAM in the EU. -Develop research methods and strategies for CAM that take into account the needs and attitudes of EU citizens and providers (funders and clinicians). -Develop research strategies and a roadmap to enable future CAM research regarding effectiveness, efficacy, cost effectiveness and safety.
WP8: Dissemination and communication
Work group members: GAMED (L), MRI, SDU, BayFOR
-To foster project internal communication and external communication with CAM stakeholders including patient and public healthcare organizations. -To establish, host and maintain a website as the common platform for CAMbrella (www.cambrella.eu).
-To identify CAM stakeholders and appropriate target audiences in Europe through which to disseminate information generated by the project.
-To plan and organize the final CAMbrella conference. 
WP9: Management
Work group members: MRI (L), Charite, BayFOR
Timeline
The Grant Agreement with the EC, which includes the final Description of Work, was duly signed on October 22, 2009 and stipulates the project's duration from January 1, 2010 to December 31, 2012. The timeline for the WPs shows that most work groups will finish their tasks by the end of 2011, allowing for the development of the research roadmap. The key events are the kick-off meeting which was held in Munich on January 21-22, 2010, and the final conference which is planned for November 2012 in Brussels.
Dissemination
The central platform for the dissemination of the information generated by CAMbrella is the project website (www.cambrella.eu) which is established, hosted and maintained by WP 8. It offers information on the current status of the project, its progress and the work plan for upcoming project milestones. The website will also be used as an instrument for disseminating reports and WP activities. The website will encourage and stimulate dialogue between the project consortium and interested parties, including the publication of a regular newsletter that combines information on the project with information on relevant CAM research results.
Comments
The CAMbrella project is a work in progress and will identify CAM stakeholders and appropriate target audiences in Europe through which to disseminate information generated by the project. The impact achieved by its developments and outcomes is multi-faceted: i) The scientific perspective: The project's WPs are designed to enhance the knowledge of CAM in the EU by developing consensus on terminology and collecting information most prevalent and relevant for EU citizens and thus eligible for future funding by the EC. It has been suggested that the strategy in CAM research should be developed in an order that differs from that commonly used for conventional medicine [13] . Such a strategy does not contain new methodological concepts, but organises existing ideas in a way that is tailored to pragmatic clinical practice. It is a framework to guide CAM research, illustrating the necessary building blocks required for a sound evidence base. Within this 5-phase research framework, pragmatic trials are proposed as a valuable complement to placebo-controlled studies as they focus on routine clinical settings and practice [14] . Intervention approaches such as psychotherapy and other more complex interventions including CAM may be slightly modified in these contexts [15] . All of these methodological issues will be considered in our proposed strategic approach. The outcome of the CAM-focused CAMbrella project is designed to contribute to the process of developing an appropriate strategy for better healthcare in Europe. This will be soundly evidence-based and is likely to involve a wide range of different interventions. 
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about CAM use, demand for CAM and the legal regulations on CAM provision. Further objectives are to identify major conditions treated with CAM and to explore the reasons why patients choose CAM. Based on the available information, a reasonable roadmap for future research projects will be suggested to fill the existing knowledge gaps and to facilitate that CAM practice is based on appropriate evidence. All actions intend to inform EU policies and decision makers in order to identify and support research programs of excellence and ensure a solid evidence base for the delivery of all aspects of healthcare to European citizens. ii) The coordination perspective: The project will create a coordinated EU network of researchers and stakeholders within the EU and beyond its borders. This network will also foster dialogue with patients, research and healthcare funders (both public and private) and specific provider groups such as homeopaths and acupuncturists. Various organisations, including those representing conventional medicine or patients' interests in general, are being encouraged to participate in the project. The information generated by the university-based, research-focused core of the collaboration will thus have a substantial and strong impact on how CAM is looked at and provided in the EU's diverse healthcare systems. With respect to the limited project time it is particularly important to look for sustainable network structures. A recently established European chapter within the International Society for CAM Research (ISCMR, www.iscmr.org) provides an infrastructure which can facilitate future use of the network developed by CAMbrella. Such cooperation is also aimed at paving the way for further research projects funded by the EU's framework programmes (FP 7, as well as FP 8 starting in 2014), while simultaneously providing a pool of linked research centres for collaborative projects.
The roadmap for future European CAM research will be based on our understanding of which research activities are
